People | The Supplement Group

Our People

Meet the passionate and dedicated team behind The Supplements Group. Our team includes renowned scientists, experienced medical professionals, and innovative researchers committed to improving health outcomes.

Irving Low

Irving brings over 20 years of executive expertise in business development, marketing, management, and consultancy across diverse industries such as financial advisory, currency markets,, ecommerce, healthcare, and wellness. His notable tenure includes roles at UBS, UOB, and AIA. Irving is an accomplished sales leader with a distinguished career in the supplements industry, having spearheaded networks of over 100,000 members across Asia. A charismatic motivator, he possesses unparalleled expertise in structuring highimpact commission and incentive plans that maximize agent performance. His strategic leadership in sales force development and revenue growth has cemented his reputation as a top-tier manager, adept at transforming teams into scalable, results-driven organizations.

Jon Lim

An MBA graduate, Jon Lim is a seasoned business leader with 25+ years of expertise in corporate finance, strategic planning, and operational leadership across biotechnology, telecom, retail, healthcare, and financial services. He has held key roles such as CFO (Asia Pacific) at HL Display, CFO (SEA) at Inventec Besta, and Group COO at Noble Vici Group, driving growth, efficiency, and financial excellence. With extensive cross-border management experience in the U.S., Europe, and APAC, Jon specializes in restructuring, M&A, IPO readiness, and corporate governance, with firms like Merrill Lynch, KLA, OCBC Bank, and Agilent Technologies. A certified PMC, he also advises companies on strategic transformation, financial restructuring, and market expansion for higher sales and profits.

Barbara Wu

Barbara is a seasoned entrepreneur with extensive experience in business setup and growth, having successfully built and exited a venture that was acquired by a NASDAQ-listed company. Holding a BSc in Business (Double Major in Marketing and Media Management) from Edith Cowan University, she began her career at SPH before founding her own marketing agency, serving prestigious clients such as Temasek, CDL, Far East Organization, Changi Group, and Kingsmen. She later divested the agency to an American firm in 2023. Earlier in her career, Barbara contributed to Baxter’s business development efforts, engaging with clinics, hospitals, and pharma companies. Beyond marketing, she is also an accomplished F&B entrepreneur, owning and operating multiple F&B establishments in Singapore.

Master Yeo

A renowned figure in Singapore’s metaphysical community, Master Yeo Chin Nam combines Taoist wisdom with holistic well-being, guiding devotees toward health, prosperity, and spiritual balance.. His Nan Tian Fu Ji Zheng Gong Temple earned the "Successful Enterprise Award" and "Singapore Brand Award (2011)" for its impactful services to the economy. Recognized by ex-PM Lee Hsien Loong for philanthropy, Master Yeo also promotes mental and emotional healing, proving tradition’s enduring relevance in contemporary wellness. for devotees and clients alike.

Dr Choong Yew Bong, MD

Dr. Choong graduated in 2009 and has since gained extensive experience across plastic surgery, hand surgery, orthopedics, urology, emergency medicine, and medical aesthetics. In 2012, he earned the prestigious Membership of the Royal Colleges of Surgeons of Edinburgh (UK) and later obtained a Diploma in Dermatology from Cardiff University (UK) in 2015, further enhancing his expertise.

Dr Fan Xiao Xiang

Dr. Fan Xiaoxiang holds a Ph.D. in Natural Sciences (Cell Biology) from the University of Duisburg-Essen, Germany. He serves as Director of the Zhongguancun National Innovation Demonstration Zone Open Laboratory. His leadership includes overseeing one major Zhongguancun industrial project and four specialized initiatives. His research focuses on cell therapy development, large-scale protein production, and biobank systems.

Wang Yun Hong

With a Master’s in Molecular Pharmacy from the Chinese Academy of Sciences and Harbin Engineering University , Ms Wang currently serves as Deputy Director of the Zhongguancun Open Laboratory for Cell Therapy and Detection and is a Co-founder of the CAS Cell Therapy Joint Laboratory. A recipient of Inner Mongolia’s Science and Technology Progress Awards (Second & Third Class), she has contributed to 2 National Natural Science Foundation projects, holds 7 patents, and has led 10+ industrial projects. Her research focuses on cell therapy industrialization, biobank development, and stem cell resource technologies.

Dr Wan Xing Zhong

Associate Professor with a Ph.D. in Chemistry (University of Portsmouth, UK). Former Associate Researcher at the Institute of Chemical Metallurgy, CAS. Licensed Pharmacist and Council Member of the Beijing Biomedical Engineering Association. With 20+ years in pharmaceutical R&D and GMP production, he has led five national key projects (NSF, 863 Program) and holds four international patents. His work on commercialized drugs (e.g., lumbrokinase) generates ¥100M+ annually. Published 7+ papers.

Dr Regina Karim, MD

Dr. Regina Karim, MD is a distinguished physician-executive with 15+ years of leadership in medical, regulatory and scientific affairs across pharmaceuticals, nutraceuticals and functional nutrition. Currently Senior Regulatory Manager at Danone (present), she drives infant formula innovation while ensuring compliance across ANZ/APAC markets. Previously at H&H Group (2018-2024), she pioneered Australia's first maternal biotics and HMO-based infant formula - award-winning innovations generating AUD$300M+ retail value. Her tenure at Danone (2012-2018) established scientific rigor in probiotic claims, including Australia's first systematic review on gut health. Earlier roles at MSD and Pfizer showcased her clinical expertise in vaccines, oncology and infectious diseases.

Jun Jin Sei

Fluent in English, Mandarin, and Korean, Jin Sei specializes in cross-border shipping finance, M&A, syndicated loans, and regulatory compliance. With experience at top international law firms and financial institutions, he advises clients on high-value transactions, including aircraft acquisitions (USD 8B), ship financing, and structured finance. Key deals include advising on a GBP 260M UK acquisition, a USD 125M loan restructuring, and LIBOR transition compliance. He holds a Bachelor of Laws (Honours) from the National University of Singapore and is a member of the Singapore Academy of Law and the Law Society of Singapore.

Eric Chew

Eric is an accomplished Transformation Leader specializing in AIdriven digital innovation, risk management, and data governance. With extensive experience leading large-scale initiatives, he currently serves as Director of an international bank where he builds AI-powered customer data platforms. During his 20-year tenure in GIC and Credit Suisse, he automated compliance and risk processes through AI and data governance. An adjunct lecturer at NTU and VP (Education) of IIBA Singapore, Eric holds a Computer Engineering degree and certifications in Generative AI, Agile, and Scrum.

Tan Jee-Yann

Tan Jee-Yann is a data-driven risk expert specializing in credit analytics, stress testing, and AI-powered financial modeling. With 18+ years at top institutions (Credit Suisse, HSBC, Deutsche Bank, KPMG), he led APAC stress testing ensuring MAS/CBIRC compliance through advanced valuation models. Previously in London (2011–2016), he optimized counterparty risk using quantitative techniques (Monte Carlo, Cholesky Decomposition). Skilled in C++, SQL, and AI applications, Jee-Yann holds a MSc in Mathematical Modelling from University College London and a BSc in Mathematics from King’s College London. He published on quantitative finance in Wilmott Magazine, showcasing his ability to model complex financial instruments